These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. AEG-35156, an antisense oligonucleotide against X-linked inhibitor of apoptosis for the potential treatment of cancer. Tamm I Curr Opin Investig Drugs; 2008 Jun; 9(6):638-46. PubMed ID: 18516763 [TBL] [Abstract][Full Text] [Related]
9. Drug evaluation: CP-751871, a human antibody against type I insulin-like growth factor receptor for the potential treatment of cancer. Sachdev D Curr Opin Mol Ther; 2007 Jun; 9(3):299-304. PubMed ID: 17608029 [TBL] [Abstract][Full Text] [Related]
16. Drug evaluation: ISIS-301012, an antisense oligonucleotide for the treatment of hypercholesterolemia. Burnett JR Curr Opin Mol Ther; 2006 Oct; 8(5):461-7. PubMed ID: 17078389 [TBL] [Abstract][Full Text] [Related]
17. The future of toll-like receptor therapeutics. Parkinson T Curr Opin Mol Ther; 2008 Feb; 10(1):21-31. PubMed ID: 18228178 [TBL] [Abstract][Full Text] [Related]
18. Technology evaluation: mapatumumab, Human Genome Sciences/GlaxoSmithKline/Takeda. Vulfovich M; Saba N Curr Opin Mol Ther; 2005 Oct; 7(5):502-10. PubMed ID: 16248286 [TBL] [Abstract][Full Text] [Related]